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Mechanisms of relaxation induced by flavonoid ayanin in isolated
aorta rings from Wistar rats
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MARÍA LUISA MARTÍN, QF, DSC1, LUIS SAN ROMÁN, QF, DSC3,
MARIO FRANCISCO GUERRERO, MD, DSC4
SUMMARY
Introduction: This study shows the relaxant effect induced by ayanin in aorta rings from Wistar rats linked to nitric oxide/
cyclic-GMP pathway.  This flavonoid is the prevalent compound obtained from Croton schiedeanus Schlecht (Euphorbiaceae),
specie used in Colombian folk medicine for the treatment of arterial hypertension.
Objectives: To identify possible action mechanisms of vascular relaxation induced by ayanin (quercetin 3,4',7-trimethyl
ether).
Methodology: Isolated aorta rings from Wistar rats obtained at the Animal House of the University of Salamanca were
contracted with KCl (80 mM) or phenylephrine (PE, 10-6 M) and exposed to ayanin (10-6-10-4 M).  Then, the effect of ayanin
was assessed in deendothelized rings contracted with PE and in intact rings contracted with PE previously incubated with:
ODQ (10-6 M), L-NAME (10-4 M), L-NAME plus D- and L-arginine (10-4 M), indomethacin (5x10-6 M), dipyridamole (3x10-7 M),
glibenclamide (10-6 M), propranolol (10-6 M), verapamil (10-7 M) or atropine (3x10-5 M).  In addition, the relaxant effect of
acetylcholine (Ach, 10-8-3x10-4 M), and sodium nitroprusside (SNP, 10-9-3x10-5 M) was assessed in the presence and absence
of ayanin (10-6 M).
Results: Ayanin induced a greater concentration-dependent relaxation in vessels contracted with phenylephrine (pEC50:
5.84±0.05), an effect significantly reduced by deendothelization and by both ODQ and L-NAME.  L-arginine was able to reverse
the effect of L-NAME.  Indomethacin weakly inhibited ayanin response.  Dipyridamole, glibenclamide, propranolol, verapamil,
and atropine did not affect ayanin relaxation.  Ayanin did not have any effect on the relaxation elicited by acetylcholine (ACh),
while weakly decreasing the relaxation induced by sodium nitroprusside (SNP).
Conclusion: Ayanin induces endothelium-dependent relaxation in the rat aorta mainly related to nitric oxide/cGMP
pathway, according to the response observed in the presence of L-NAME, L-arginine and ODQ.
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Mecanismos de relajación inducidos por el flavonoide ayanina en la aorta de ratas Wistar
RESUMEN
Introdución: Este estudio muestra el efecto vasodilatador inducido por ayanina en anillos de aorta de ratas Wistar
vinculado con la vía óxido nítrico/GMP-cíclico. Este flavonoide es el compuesto mayoritario aislado de Croton schiedeanus
Schlecht (Euphorbiaceae), especie utilizada en la medicina popular colombiana para el tratamiento de la hipertensión arterial.
Objetivos:  Identificar los posibles mecanismos vasodilatadores inducidos por la ayanina (quercetin 3,4',7-trimetileter).
Metodología: Se adicionó ayanina (10-6 - 10-4 M) a anillos aislados de aorta procedentes de ratas Wistar contraídos con
KCl (80 mM) o fenilefrina (10-6 M). Luego se evaluó el efecto de la ayanina en anillos sin endotelio contraídos con fenilefrina
y en anillos íntegros, contraídos con fenilefrina, previamente incubados con: ODQ (10-6 M), L-NAME (10-4 M), L-NAME más
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L- o D-arginina (10-4 M), indometacina (5x10-6 M), dipiridamol
(3x10-7 M), glibenclamida (10-6 M), propranolol (10-6 M),
verapamilo (10-7 M) o atropina (3x10-5 M). Además se examinó
la relajación inducida por acetilcolina (Ach, 10-8-3x10-4 M) y
nitroprusiato de sodio (SNP, 10-9-3x10-5 M) en presencia y
ausencia de ayanina (10-6 M).
Resultados:  La ayanina produjo una mayor relajación en
los anillos contraídos con fenilefrina (pEC50: 5.84±0.05), efec-
to que se redujo en anillos sin endotelio o en anillos íntegros
preincubados con ODQ y L-NAME. L-arginina fue capaz de
revertir la respuesta inducida por L-NAME. La indometacina
inhibió discretamente la relajación generada por la ayanina. El
dipyridamol, la glibenclamida, el propranolol, el verapamilo y
la atropina no modificaron el efecto de la ayanina. La ayanina
no afectó la relajación inducida por la acetilcolina y débilmen-
te disminuyó la inducida por el nitroprusiato de sodio.
Conclusión: La ayanina induce una relajación depen-
diente del endotelio en la aorta de rata, efecto vinculado
principalmente con la vía de óxido nítrico/GMP cíclico, de
acuerdo con la respuesta observada en presencia de L-
NAME, ODQ y L-arginina.
Palabras clave: Ayanina; Croton; Factores relajantes
endotelio-dependientes; Flavonoides; Aorta.
Polyphenolic compounds have extensively
demonstrated beneficial cardiovascular effects in
humans1-4.  Among them, flavonoids constitute a large
group of phenolic phytochemicals, which have been
widely described in the literature as vasodilator
compounds5-9.  Most flavonoids described to date exhibit
a relaxant effect independent of the presence of a
functional endothelium6,9,10, however, endothelium-
dependent vasorelaxant effects have also been reported
for some of these compounds8,11-13.
Screening tests of medicinal plants used by Colombian
folk tradition as antihypertensives, found that ethanolic
and aqueous extracts of Croton schiedeanus Schlecht
(Euphorbiaceae) were able to decrease blood pressure
in spontaneously hypertensive rats and to elicit significant
vasorelaxant effects in isolated aorta rings14 .
Consequently a bio-guided phytochemical fractionating
was performed to identify their active principles, and
ayanin (quercetin 3,4',7-trimethyl ether) (Figure 1) was
isolated as one of them15.
The relaxant properties of ayanin on smooth muscle
have been demonstrated in isolated tracheal rings16, but
until now, its potential profile as a vasorelaxant agent is
not sufficiently known.  Therefore, the aim of this work
was to investigate whether ayanin relaxant mechanisms
are due to interactions with one of the following key
vascular factors: endothelium, NO/cyclic GMP pathway,
prostanoid, K+ATP  channels, L-type calcium channels,
??receptors or muscarinic receptors.
MATERIALS AND METHODS
Extraction and isolation of ayanin. Ayanin
(quercetin 3,4',7-trimethyl ether) (Figure 1) was isolated
from C. schiedeanus Schlecht (Euphorbiaceae) ,  a
plant collected from the region of Tocaima,
Cundinamarca, Colombia in November 1998 (voucher
nº 432164). The aerial part of this specie was
exhaustively extracted with 96% EtOH at room
temperature. The combined extracts were concentrated
under reduced pressure and partitioned to yield an
aqueous extract and CHCl3.  The residue of the CHCl3
extract was fractionated with 4% NaOH.  Then ayanin
was isolated from the neutral part by flash
chromatography over silica gel with hexane-EtOAc
(1:1).  Ayanin was identified by comparing m-p., 1H-
NMR, 13C-NMR values with that reported17,18.
Rat aorta ring preparation. The experiments were
conducted at the Pharmacology Laboratory in the School
of Pharmacy at the University of Salamanca. Male
Wistar rats (320-400 g) from the Animal House (PAE-
SA001) were anaesthetized with ether and beheaded.
The descending thoracic aorta was dissected and placed
in an oxygenated Krebs solution with the following
composition (in mM): NaCl, 118.0; KCl, 4.75; CaCl2,
1.8; MgSO4, 1.2; KH2PO4, 1.2; NaHCO3, 25; glucose,







Figure 1. Chemical structure of ayanin
(quercetin 3,4´,7-trimethyl ether)
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Rings of thoracic aorta (4-6 mm long) were carefully
excised and submerged in tissue bath chambers
containing 5 ml of Krebs solution of bathing medium
maintained at 37ºC and bubbled with 95% O2 and 5%
CO2 gas mixture (pH=7.4).  Rings were mounted by
means of two parallel L-shaped stainless-steel holders
inserted into the lumen. One holder served as an anchor,
while the other was connected to a force-displacement
transducer (Harvard UF1) to measure isometric
contractile force recorded by a MacLab/8-computer
system (AD InstruMents Ltd, London, UK).  The rings
were stretched progressively to an optimal basal tension
of 2 g, determined by length-tension relationship
experiments and, then, allowed to equilibrate for 60 min.,
and changing the bath fluid every 15-20 min.  When
necessary, the endothelium was removed by rubbing the
intimal surface with a wooden stick.  The presence of
functional endothelium was assessed by the ability of
ACh (10-6 M) to induce more than 50% relaxation of
rings pre-contracted with phenylephrine (PE, 10-6 M)19.
Each preparation was allowed to equilibrate for at least
60 min. prior to initiation of experimental procedures and
during this period, the incubation media were changed
every 20 min. before the addition of drugs.
Ethical issues. In all of these experiments, the
provisions regarding the protection of animals used for
experimental purposes in current Spanish legislation
(Real Decreto 1201/2005), European Community (EEC
86/609) and specifications were adhered to.
Experimental procedures. To observe if ayanin
induces relaxant effects, intact aorta rings incubated in
Krebs solution were stimulated with PE (10-6 M) or high
KCl (80 mM) until the contractile response reached a
steady tension. Then ayanin was added in progressively
cumulative concentrations (10-7-10-4 M) at 30 min.
intervals.
To study possible mechanisms related to the relaxant
effects induced by ayanin, the following protocols were
performed: First, the roll of endothelium was studied
adding the flavonoid in similar way in deendothelized PE
contracted rings. To assess whether nitric oxide, cGMP,
phosphodiesterase-5, K+ATP  channels, prostanoid, beta-
receptor, L-type calcium channels, or muscarinic
receptors are related to the relaxant mechanisms induced
by ayanin, this flavonoid was added to rings contracted
with PE treated 30 min. previously with one of the
following substances, respectively: L-NAME (10-4 M
[Nw-nitro-L-arginine methyl ester hydrochloride]), a
NO synthase inhibitor; ODQ (10-6 M [1H-[1,2,4]
oxadiazolo[4,3-a]quinoxalin-1-one]), a guanylate cyclase
inhibitor; dipyridamole (3x10-7  M), a cGMP-
phosphodiesterase 5 inhibitor;  glibenclamide (10-6 M), a
K+ATP  channel blocker; indomethacin (5x10
-6 M), a
cyclooxygenase (COX) inhibitor; propranolol (10-6 M),
a ?-adrenoceptor blocking agent; verapamil (10-7 M), a
L-type calcium channels blocker and atropine (3x10-5
M), a muscarinic receptor blocking agent.
To advance in possible interactions with NO/cGMP
pathway the inactive a-amino acid D-arginine or the
active L-arginine (10-4 M, substrate for NO synthesis)
were added (10 min. before) to rings incubated with L-
NAME (10-4 M). In addition, ayanin (10-6 M) was added
(30 min. before) to rings contracted with PE (10-6 M)
exposed to Ach (10-8-3x10-4 M) or SNP (10-9-3x10-5 M),
added at 30 s intervals.
Experiment design and data analysis. In all
instances, the dependent variable was the relaxant
response obtained as a percentage of the maximal
contraction induced by PE (10-6 M) or KCl (80 mM).
Sigmoidal regression to lead pEC50 values (- log of the
molar concentration of agonist to produce 50% of the
maximal relaxation in contracted rings) were obtained
from concentration-response curves. Each point
represents the means ± SEM of at least five experiments.
Analysis of variance with Dunnett´s post test were
applied to compare three or more groups and Student t
test to compare two groups. p<0.05 was considered
significant. The GraphPad Sofware (version 4.0; San
Diego, CA, USA) was used for data analysis.
Drugs and chemicals. The following salts and
drugs were used: NaCl, CaCl2, NaHPO4, NaHCO3 ,
glucose (Panreac), KCl, MgCl2, KH2PO4 and MgSO4
(Probus), ascorbic acid (Prolabo), phenylephrine
hydrochloride, acetylcholine chloride, indomethacin, L-
NAME, L-arginine, D-arginine, ODQ, dipyridamole,
glibenclamide, dimethylsulfoxide, verapamil hydro-
chloride, sodium nitroprusside, atropine sulfate, and
propranolol hydrochloride (Sigma-Aldrich).  Ayanin,
glibenclamide and dipyridamole was dissolved in DMSO.
All other substances were dissolved in physiological
saline solution.  The final DMSO concentrations in the
bathing media were always less than 0.1%. Control
tests demonstrated that this amount of DMSO failed to
exhibit any response.
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RESULTS
The maximal contractile response obtained with KCl
and PE in intact aorta rings was 3335 ± 197 mg (n=26)
and 3439±165 (n=52), respectively. In de-endothelized
rings PE elicited a contraction of 3126±161 (n=33)
(Table 1). Ayanin induced a greater relaxant effect
against PE (pEC50=5.84±0.05) than KCl (Table 1,
Figure 2).
Pretreatment of the endothelium-intact rings with L-
NAME (Figure 3) or ODQ (Figure 4) significantly
reduced ayanin-induced relaxation. The effects of L-
NAME was completely reversed by L-arginine
(pEC50=5.61±0.04), but not by D-arginine (Table 1,
Figure 3).
The relaxant response to ayanin was not affected by
pretreatment with dipyridamole, atropine, verapamil or
propranolol (Table 1), and slightly by indomethacin
(Figure 4).  Finally, ayanin unchanged the ACh relaxing
effect (pEC50=7.55±0.04) and slightly modified SNP
relaxation (pEC50=7, Table 2, Figure 5).
DISCUSSION
The results of ayanin in KCl- and PE-intact rings and
in PE de-endothelized rings show that this flavonoid
Table 1
Vasorelaxant effect of ayanin against KCl (80 mM) and phenylephrine (PE, 10-6 M)
alone and in the presence of different receptor antagonists in rat aorta rings
          Treatment                                      PE-contraction (mg) pEC50           Maximal response (Emax)
Data are the mean ± SEM. n>5 experiments. pEC50 represents -log molar concentration of ayanin to produce 50% of the maximal relaxation.
Emax, maximal relaxation (%). *p<0.05 compared with PE (10-6 M). ND, not determined.
exerts anti-adrenergic effect of endothelium-dependent
origin. Subsequent experiments with the NO synthase
inhibitor L-NAME and ODQ, a guanilyl cyclase inhibitor,
which were able to reduce markedly ayanin vaso-
dilatation, support a NO/cGMPc dependent mechanism.
Figure 2. Concentration-response induced by ayanin
in endothelium-intact rat aorta rings contracted
with phenylephrine (PE, 10-6 M) or KCl (80 mM),
*p<0.05 (Student t test).
KCl (80 mM) 3335 ± 197 ND 35.47 ± 3.65*
PE (10-6 M) 3439 ± 165 5.84 ± 0.05 92.99 ± 1.30
L-NAME (10-4 M) + PE 4882 ± 189* ND 32.99 ± 7.14*
ODQ (10-6 M) + PE 5242 ± 101* ND 40.88 ± 5.50*
L-ARG (10-4 M) + L-NAME (10-4 M) + PE 3834 ± 201 5.61 ± 0.04 93.02 ± 2.66
D-ARG (10-4 M) + L-NAME (10-4 M) + PE 4972 ± 158* ND 30.12 ± 6.07*
Indomethacin (5x10-6 M) + PE 3876 ± 182* 5.43 ± 0.04* 90.70 ± 2.27
Dipyridamole (3x10-7 M) + PE 2300 ± 205* 6.05 ± 0.16 92.29 ± 2.49
Verapamil (10-7 M) + PE 1694 ± 108* 5.99 ± 0.11 95.10 ± 1.54
Glibenclamide (10-6 M) + PE 2818 ± 159 5.90 ± 0.01 96.61 ± 3.61
Propranolol (10-6 M) + PE 3587 ± 186 5.92 ± 0.09 87.97 ± 3.21
Atropine (3x10-5 M) + PE 2945 ± 205 5.82 ± 0.07 90.98 ± 4.02
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It is noticeable that L-arginine (the substrate for NO
synthesis), but not D-arginine, was able to reverse the
inhibitory effects induced by L-NAME against ayanin.
These findings suggest that ayanin enhances the
production of NO from L-arginine in the vascular
endothelium.  It is known that nitric oxide (the endothelium
derived relaxing factor, EDRF)20  activates soluble
guanylyl cyclase, causing the formation of cyclic GMP
and subsequently vascular relaxation21. Since ODQ
interferes directly with soluble guanylyl cyclase activated
Table 2
Effect of ayanin (10-6 M) on the relaxant responses of acetylcholine (ACh, 10-8-3x10-4 M) and
sodium nitroprusside (SNP, 10-9-3x10-5 M) in endothelium-intact aorta rings precontracted
with phenylephrine (PE, 10-6 M)
                    Treatment                        PE-contraction (mg)             pEC50 Maximal response(Emax)
Data are the mean ± SEM of >5 experiments. pEC50 represents -log molar concentration of Ach or SNP to produce 50% of the maximal
relaxation. E max, maximal relaxation (%). *p<0.05 compared with PE (10-6 M) (E+). ND, not determined.
Figure 3. Concentration response induced by ayanin
in endothelium-intact rat aorta rings contracted
with phenylephrine (PE, 10-6 M), in absence and
presence of: L-NAME (10-4 M), L-NAME plus L-arginine
(10-4 M) and L-NAME plus D-arginine (10-4 M), *p<0.05
(Anova and Dunnett tests).
Figure 4. Concentration response induced by ayanin
in endothelium-intact rat aorta rings contracted
with phenylephrine (PE, 10-6 M) in absence and
presence of ODQ (10-6 M) or indomethacin (5x10-6 M),
*p<0.05 (Anova and Dunnett tests).
by NO22, relaxation induced by ayanin may be related to
the production of NO, resulting in an increase of the
cGMP in the endothelium.
The cellular accumulation of cGMP depends upon
the rate of their synthesis and their breakdown. The
latter is achieved by cyclic nucleotide phosphodiesterase
(PDE) isoforms PDE1 and/or PDE523 isolated in
vascular smooth muscle cells. The potentiating of
vasodilator effects of agents that increase cGMP has
become a simple test to study the possible role of PDE
ACh (10-8-3x10-4 M) 3439 ± 165 7.82 ± 0.02 64.41 ± 3.25
Ayanin (10-6 M)+ ACh (10-8-3x10-4 M) 3192 ± 202 7.55 ± 0.04 71.73 ± 3.15
SNP (10-9-3x10-5 M) 3439 ± 165 8.38 ± 0.006 100.00 ± 0.00
Ayanin (10-6 M)+ SNP (10-9-3x10-5 M) 3192 ± 202 8.08 ± 0.01* 99.92 ± 0.08
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inhibition in the relaxant effect of vasodilators. In these
experiments, ayanin slightly increased the relaxant effect
of SNP, a NO donor. Furthermore, dipyridamole, a
cGMP-PDE5 inhibitor did not modify the relaxant
responses to ayanin. Hence, these results suggest that
inhibition of the GMP-dependent PDE is not mainly
linked to the vasodilator effect of ayanin.
Blockage of cyclo-oxygenase by indomethacin
(5x10-6 M) produced a rightward shift in the concentration-
response curve for ayanin.  The pEC50 value of ayanin in
the presence of the indomethacin was significantly
decreased from 5.84±0.05 to 5.43±0.04 (p<0.05, Figure 4,
Table 1). Therefore, it is possible in some degree that
endothelial vasorelaxant factors derived from cyclo-
oxigenase participated in the relaxant effect of ayanin.
Also, according to experiments with: atropine, a
muscarinic receptor antagonist; verapamil, a L-type calcium
channel blocking agent; propranolol, a ?-adrenoceptor
blocking agent; and glibenclamide, a K+ATP  channel
blocker (Table 1), it can be presumed that muscarinic
agonism, beta agonism, voltage-dependent calcium channel
activation, and K+ATP  channel activation do not seem
important action mechanisms related to the ayanin relaxant
profile. However, these observations do not rule out the
possibility that other types of pharmaco-dynamic inter-
actions may mediate ayanin-induced relaxation.
In conclusion, the ayanin flavonoid induces
endothelium-dependent relaxation in Wistar rat aorta
mainly related to NO/cGMP pathway. Further work is
necessary to clarify the mechanisms involved in this
effect. Since ayanin is the predominant compound
isolated from C. schiedeanus («almizclillo»), it is highly
probable that it plays an important role in the cardio-
vascular effects described for this specie.  These results
support the traditional use of C. schiedeanus for the
treatment of arterial hypertension.
Figure 5. Concentration response induced by acetylcholine (ACh, 10-8-3x10-4 M) and sodium
nitroprusside (SNP, 10-9-3x10-5 M) in endothelium-intact rat aorta rings contracted with
phenylephrine (PE, 10-6 M) in absence and presence of ayanin (10-6 M), *p<0.05 (Student t test)
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